S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

MREO Mereo BioPharma Group PLC

3.98

0.00 (0.00%)

Pre Market

Last Updated: 21:00:00

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Mereo BioPharma (NASDAQ:MREO)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Mereo BioPharma Charts.

Mereo BioPharma (NASDAQ:MREO)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Mereo BioPharma Charts.

Mereo BioPharma Group PLC News

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 18 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 15 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Saturday 15 June 2024 (1 month ago) • Edgar (US Regulatory)

Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
Friday 14 June 2024 (1 month ago) • GlobeNewswire Inc.

Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)
Wednesday 12 June 2024 (1 month ago) • GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Wednesday 12 June 2024 (1 month ago) • Edgar (US Regulatory)

Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference
Thursday 30 May 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 24 May 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 24 May 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 24 May 2024 (2 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 16 May 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 16 May 2024 (2 months ago) • Edgar (US Regulatory)

More Mereo BioPharma Group PLC News Articles

NLBNPIT1Z7J8 20991231 11...

NLBNPIT1WWU7 20351221 9....

NLBNPIT20532 20241220 650

NLBNPIT1XG49 20991231 7....

NLBNPIT1Z661 20991231 11...

NLBNPIT20J43 20351221 19...

XS2751593950 20280229 32...

NLBNPIT1USJ2 20991231 74...

NLBNPIT210O1 20991231 12...

NLBNPIT1ZGN8 20241220 10

NLBNPIT1Z1Y0 20991231 21...

NLBNPIT208Q0 20991231 11...

NLBNPIT1S3Y5 20241220 350

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions